business π Molbio Diagnostics IPO GMP hints at listing gains
Molbio Diagnostics' Rs 940 crore IPO closes for subscription today, with a GMP of Rs 136. This signals a potential listing gain of 16.85% above the upper price band of Rs 807. The IPO was heavily subscribed, with QIBs subscribing 73.70 times. The issue, which opened on August 10, closes on August 12. Proceeds will fund R&D infrastructure and equipment for various units.